Trials / Unknown
UnknownNCT06703866
Value-Based Medicine (VBM) for Lung Cancer
Validation of Predictive Model in Value-based Medicine for Lung Cancer and Analysis of Its Implications for Patient Communication
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- European Institute of Oncology · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective observational monocentric trial. The primary endpoint is the validation of predictive models. These predictive models will be used to develop a personalized clinical-functional risk profile for estimating in advance, prior to surgery, the probability for a patient to experience surgical complications, pain, fatigue, dyspnea, as well as issues related to physical function, role, social, and emotional well-being, up to 12 months post-discharge.
Detailed description
The goal of this prospective observational monocentric study is to validate a predictive models in patients with diagnosis of non-small cell lung cancer eligible for surgical lung resection (lobectomy/typical and atypical segmentectomy) with or without neo-adjuvant and adjuvant therapy. Participants will be asked to complete quality of life questionnaires before surgery and then at 30 days, 4 months, 8 months and 12 months post discharge. The informations collected through questionnaires, along with clinical data will be used to validate the predictive models created. These models will then be utilized to develop a personalized clinical-functional risk profile for estimating in advance, prior to surgery, the probability for a patient to experience surgical complications, pain, fatigue, dyspnea, as well as issues related to physical function, role, social, and emotional well-being, up to 12 months post-discharge.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non Small Cell Lung Cancer (NSCLC) | Application of "value based medicine" predictive model |
Timeline
- Start date
- 2021-01-27
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2024-11-25
- Last updated
- 2024-11-25
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06703866. Inclusion in this directory is not an endorsement.